from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2222c/glnA2

LFCtreatmentdescriptionclass of inhibitor

1.088

Amikacinug/mL Amikacintranslation

1.015

Cap5-10ug/mL Capreomycintranslation

1.285

Rox10-50 ug/mL Roxithromycintranslation

0.637

SM2-5 ug/mL Streptomycintranslation

1.641

Tet5-10 ug/mL Tetracyclinetranslation

-2.326

Rif0.2-5ug/mL Rifampicintranscription

-1.465

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.017

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.733

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.020

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.273

Clofazimine10-13 ug/mL Clofaziminerespiration

0.065

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.721

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.415

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.217

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.159

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.228

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.242

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.556

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.265

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.955

KCN5-20 ug/mL Potassium cyaniderespiration

0.861

NaN30.2-2 mM Sodium aziderespiration

0.214

Nigericin50 uM Nigericinrespiration

-1.299

TRC10-150 ug/mL Triclosanrespiration

-0.068

TRZ10-25 ug/mL Thioridazinerespiration

0.068

Valinomycin0.5-10 uM Valinomycinrespiration

0.355

ZnSO42 mM ZnSO4respiration

0.503

menadione6-10 ug/mL Menadionerespiration

-0.417

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.034

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.492

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.660

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.843

NRP_1Non-replicating persistence stage 1dosRassociated

0.050

Amp0.2mg/mL AmpicillincellWall

0.564

Cephalexin20-100 ug/mL CephalexincellWall

0.132

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.507

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.452

EMB10-20 ug/mL EthambutolcellWall

0.552

Eta12-40 ug/mL EthionamidecellWall

0.944

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.066

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.196

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.293

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.130

BZA0.12 mg/mL BenzamidearomaticAmides

0.544

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.169

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.970

H2O24 mM hydrogen peroxideDNAdamaging

-0.414

Levo10 ug/mL LevofloxacinDNAdamaging

-0.318

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.394

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.756

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.386

UVUV-irradiationDNAdamaging

0.616

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.294

Antimycin12.5-50 ug/mL Antimycin A?

0.082

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.016

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.297

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.443

PA8240.2-2 ug/mL PA-824?

0.989

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.425

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.085

Verapamil50 uM Verapamil?

-0.276

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.245

methoxatin10-20 ug/mL Methoxatin?